New hope for tough leukemia: experimental drug targets resistant cancers
NCT ID NCT06549790
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new drug, NMS-03597812, in adults with acute myeloid leukemia that has come back or not responded to standard treatments. The goal is to find a safe dose and see if the drug can shrink or control the cancer. About 124 people will take part, including those with a specific gene change (TP53 mutation) that often makes the disease harder to treat.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Blood and Marrow Transplant Group of Georgia
RECRUITINGAtlanta, Georgia, 30342, United States
-
City of Hope - Duarte
RECRUITINGDuarte, California, 91010, United States
-
Gabrail Cancer Research Center
RECRUITINGCanton, Ohio, 44718, United States
-
Mayo Clinic Cancer Center (MCCC) - Rochester
WITHDRAWNRochester, Minnesota, 55905, United States
-
Medical Oncology Hematology Consultants
RECRUITINGNewark, Delaware, 19713, United States
-
Rocky Mountain Cancer Centers
RECRUITINGAurora, Colorado, 80012, United States
-
The University of Texas MD Anderson Cancer Center
RECRUITINGHouston, Texas, 77030, United States